Citius Pharmaceuticals adds new member to Scientific Advisory Board
Genmab signs collaboration and exclusive license agreement with Immatics Biotechnologies
Dermavant Sciences to purchase rights to tapinarof from GSK
Genentech submits supplemental New Drug Application for Venclexta to US FDA
The US FDA approves the first drug TPOXX for treatment of smallpox
Guardant Health names new general manager of its LUNAR program
Otsuka Pharmaceutical acquires Visterra
US FDA grants Merck's Keytruda priority review for new supplemental biologics license application
AbbVie fails to meet goal in DBL3001 trial of Ibrutinib (IMBRUVICA)
GSK confirms deal with Dermavent Sciences
Citius Updates Progress on Test Site Acquisition for Mino-lok Phase 3 Trial
Bio-Techne Uses CRISPR Gene Editing System to Validate Antibodies in KO Cell Lines
Aeromics Begins Phase 1 Trial of Anti-Edema Therapy in Ischemic Stroke